[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100486300":3},{"organization":4,"armGroups":7,"interventions":39,"overallOfficials":65,"centralContacts":10,"locations":10,"responsibleParty":72,"collaborators":10,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":10,"eligibilityCriteria":80,"healthyVolunteers":76,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":10,"studyType":87,"phases":10,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":95,"whyStopped":10,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":10},{"fullName":5,"class":6},"Medical University of Bialystok","OTHER",[8,19,23,27,31,35],{"label":9,"type":10,"description":11,"interventionNames":12},"G1a - women",null,"The G1a group consisted of women with obesity, in whom no additional components of the metabolic syndrome were found (n =16)",[13,14,15,16,17,18],"Diagnostic Test: body composition analysis","Other: anthropometric measurements","Other: Interview questionnaire","Diagnostic Test: biochemical parameters","Diagnostic Test: cardiopulmonary fitness test","Other: nutritional interview",{"label":20,"type":10,"description":21,"interventionNames":22},"G1b - men","The G1b group consisted of men with obesity, in whom no additional components of the metabolic syndrome were founds (n =6)",[13,14,15,16,17,18],{"label":24,"type":10,"description":25,"interventionNames":26},"G2a - women","The G2a group consisted of women with obesity, in whom only one additional component of the metabolic syndrome was found (e.g. triglycerides ≥ 150 mg\u002Fdl, HDL cholesterol in women \\\u003C 50 mg\u002Fdl, and in men \\\u003C 40 mg\u002Fdl, or glycaemia ≥ 100 mg\u002Fdl), but it was not a disease previously diagnosed and treated (n=19)",[13,14,15,16,17,18],{"label":28,"type":10,"description":29,"interventionNames":30},"G2b - men","The G2a group consisted of men with obesity, in whom only one additional component of the metabolic syndrome was found (e.g. triglycerides ≥ 150 mg\u002Fdl, HDL cholesterol in women \\\u003C 50 mg\u002Fdl, and in men \\\u003C 40 mg\u002Fdl, or glycaemia ≥ 100 mg\u002Fdl), but it was not a disease previously diagnosed and treated (n=11)",[13,14,15,16,17,18],{"label":32,"type":10,"description":33,"interventionNames":34},"G3a - women","Group G3a consisted of women who met the full criteria for diagnosing the metabolic syndrome (n=24)",[13,14,15,16,17,18],{"label":36,"type":10,"description":37,"interventionNames":38},"G3b - men","Group G3a consisted of men who met the full criteria for diagnosing the metabolic syndrome (n=15)",[13,14,15,16,17,18],[40,45,49,53,57,61],{"type":41,"name":42,"description":43,"armGroupLabels":44,"otherNames":10},"DIAGNOSTIC_TEST","body composition analysis","A body composition analysis was performed using the bioelectroimpedance method using the Maltron BioScan 920-2 analyzer",[9,20,24,28,32,36],{"type":6,"name":46,"description":47,"armGroupLabels":48,"otherNames":10},"anthropometric measurements","An assessment of the status of nutrition based on anthropometric measurements was carried out.",[9,20,24,28,32,36],{"type":6,"name":50,"description":51,"armGroupLabels":52,"otherNames":10},"Interview questionnaire","An interview questionnaire concerning the duration of obesity and past diseases was collected. Moreover, the diet and nutritional status were assessed.",[9,20,24,28,32,36],{"type":41,"name":54,"description":55,"armGroupLabels":56,"otherNames":10},"biochemical parameters","The concentrations of the following parameters were determined from the blood serum: fasting glucose, fasting insulin, total cholesterol, LDL cholesterol fraction, HDL cholesterol fraction, triglycerides, C-reactive protein (CRP), uric acid, creatinine, and aminotrasferases: alanine (ALT) and aspartate (AST). On the basis of fasting glucose and fasting insulin, the HOMA - IR insulin resistance index was calculated.",[9,20,24,28,32,36],{"type":41,"name":58,"description":59,"armGroupLabels":60,"otherNames":10},"cardiopulmonary fitness test","Cardiopulmonary fitness was assessed using the Modified Bruce protocol",[9,20,24,28,32,36],{"type":6,"name":62,"description":63,"armGroupLabels":64,"otherNames":10},"nutritional interview","A 7-day nutrition interview was collected. The supply of energy, protein (including amino acids), fat (including fatty acids), carbohydrates, dietary fiber, vitamins and minerals in the usual diet was assessed.",[9,20,24,28,32,36],[66,69],{"name":67,"affiliation":5,"role":68},"Katarzyna Witczak - Sawczuk, PhD","STUDY_DIRECTOR",{"name":70,"affiliation":5,"role":71},"Lucyna Ostrowska, Professor","STUDY_CHAIR",{"type":73,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100486300","the-impact-of-the-distribution-of-adipose-tissue-on-the-occurrence-of-metabolic-disorders-and-the-level-of-cardiopulmonary-fitness-100486300",false,"NCT05612282","The Impact of the Distribution of Adipose Tissue on the Occurrence of Metabolic Disorders and the Level of Cardiopulmonary Fitness","The Impact of the Distribution of Adipose Tissue on the Occurrence of Metabolic Disorders and and the Level of Cardiopulmonary Fitness","Inclusion Criteria:\n\n* primary obesity\n* BMI ≥ 30kg\u002Fm2 - ≤ 39,99 kg\u002Fm2\n* gender: women and men\n* age: 20-65 lat\n\nExclusion Criteria:\n\n* secondry obesity\n* BMI ≥ 40 kg\u002Fm2\n* diabetes type 2 or insulin resistance (occurance or treatment)\n* endocrine disorders\n* eating disorders\n* hormonal contraception\u002Fhormone replacement therapy\n* after steroid therapy\n* antiretroviral therapy\n* musculoskeletal dysfunctions\n* patients after surgery (min 3 months)\n* bariatric surgery\n* coronary artery disease\n* cardiac pacemaker\n* pregnancy\n* breast - feeding","ALL","20 Years","65 Years",{"count":85,"type":86},91,"ACTUAL","OBSERVATIONAL","The aim of the research was to assess the impact of the distribution of abdominal fat (subcutaneous SAT and visceral VAT estimated at the height of the navel) on selected metabolic parameters and on specific parameters of cardiopulmonary fitness in terms of people with obesity.",[90],"Obesity, Abdominal",[92,93,94],"Adipose tissue","obesity","metabolic disorders","COMPLETED","2022-11-04",{"date":98,"type":86},"2022-11-10",{"date":100,"type":86},"2016-11-11",{"date":102,"type":86},"2017-10-31",{"name":5,"class":6}]